Recent valves used for transluminal implantation in patients with aortic valve stenosis

Recent Patents on Cardiovascular Drug Discovery

Volumn 7, Issue 3, 2012, Pages 206-215

  Toutouzas, Konstantinos P ^a   Stathogiannis, Konstantinos E ^a   Latsios, George S ^a   Synetos, Andreas G ^a   Stefanadis, Christodoulos I ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Aortic stenosis; CoreValve; JenaValve; Patents; Sapien; Symetis TAVI

Indexed keywords

CHROMIUM; COBALT; NITINOL;

AORTA VALVE PROSTHESIS; AORTA VALVE STENOSIS; BALLOON CATHETER; HEART SURGERY; HEART VALVE BIOPROSTHESIS; HUMAN; MORTALITY; NITINOL STENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; SELF EXPANDING STENT; SURVIVAL RATE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TREATMENT OUTCOME; VASCULAR ACCESS;

AORTIC VALVE; AORTIC VALVE STENOSIS; CARDIAC CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; PROSTHESIS DESIGN;

EID: 84870206593     PISSN: 15748901     EISSN: None     Source Type: Journal    
DOI: 10.2174/157489012803832766     Document Type: Review

References (62)

1. Stefanadis C, Wooley CF, Bush CA, Kolibash AJ, Boudoulas H. Aortic distensibility abnormalities in coronary artery disease. Am J Cardiol 1987; 59:1300-4.
2. Stefanadis C, Vlachopoulos C, Karayannacos P, Boudoulas H, Stratos C, Filippides T, et al. Effect of vasa vasorum flow on structure and function of the aorta in experimental animals. Circulation 1995; 91: 2669-78.
3. Stefanadis CI, Karayannacos PE, Boudoulas HK, Stratos CG, Vlachopoulos CV, Dontas IA, et al. Medial necrosis and acute alterations in aortic distensibility following removal of the vasa vasorum of canine ascending aorta. Cardiovasc Res 1993; 27: 951-6.
4. Lester SJ, Heilbron B, Gin K, Dodek A, Jue J. The natural history and rate of progression of aortic stenosis. Chest 1998; 113:1109-14.
5. Otto CM. Timing of aortic valve surgery. Heart 2000; 84: 211-8.
6. Bouma BJ, van Den Brink RB, van Der Meulen JH, Verheul HA, Cheriex EC, Hamer HP, et al. To operate or not on elderly patients with aortic stenosis: The decision and its consequences. Heart 1999; 82:143-8.
7. Charlson E, Legedza AT, Hamel MB. Decision-making and outcomes in severe symptomatic aortic stenosis. J Heart Valve Dis 2006;15:312-21.
8. Pellikka PA, Sarano ME, Nishimura RA, Malouf JF, Bailey KR, Scott CG, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005;111:3290-5.
9. Ross J, Jr., Braunwald E. Aortic stenosis. Circulation 1968; 38: 61-7.
10. Toutouzas K, Drakopoulou M, Synetos A, Tsiamis E, Agrogiannis G, Kavantzas N, et al. In vivo aortic valve thermal heterogeneity in patients with nonrheumatic aortic valve stenosis the: First in vivo experience in humans. J Am Coll Cardiol 2008; 52: 758-63.
11. Kodali SK, Williams MR, Smith CR, Svensson LG, Webb JG, Makkar RR, et al. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med 2012; 366: 1686-95.
12. Lefevre T, Kappetein AP, Wolner E, Nataf P, Thomas M, Schachinger V, et al. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J 2011; 32:148-57.
13. Moat NE, Ludman P, de Belder MA, Bridgewater B, Cunningham AD, Young CP, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011; 58: 2130-8.
14. Rodes-Cabau J, Webb JG, Cheung A, Ye J, Dumont E, Feindel CM, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010;55:1080-90.
15. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, et al. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012;366:1705-15.
16. Holmes DR, Jr., Mack MJ, Kaul S, Agnihotri A, Alexander KP, Bailey SR, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: Developed in collabration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Thorac Cardiovasc Surg 2012; 144: e29-84.
17. Toutouzas K, Michelongona A, Synetos A, Latsios G, Drakopoulou M, Stefanadis C. Transcatheter aortic valve implantation during the acute phase of acute myocardial infarction. Int J Cardiol 2011; 152: 398-400.
18. Moulopoulos, S. Catheter mounted artificial heart valve for implanting in close proximity to a defective natural heart valve. US3671979 (1972).
19. Boretos, J.W., Poirier, R.A. Aortic heart valve catheter. US4056854 (1977).
20. Hillstead, R.A. Endovascular stent apparatus and method. US4856516 (1989).
21. Palmaz JC. Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft. US4733665 (1988).
22. Andersen HR, Knudsen LL, Hasenkam JM. Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992;13:704-8.
23. Andersen, H.R., Hasenkam, J.M., Knudsen, L.L. Valve prosthesis for implantation in the body. US6168614 (2001).
24. Andersen, H.R., Hasenkam, J.M., Knudsen, L.L. System and method for implanting cardiac valves. US5840081 (1998).
25. Andersen, H.R., Hasenkam, J.M., Knudsen, L.L. Valve prothesis for implantation in the body and a catheter for implanting such valve prothesis. US5411552 (1995).
26. Bonhoeffer P, Boudjemline Y, Qureshi SA, Le Bidois J, Iserin L, Acar P, et al. Percutaneous insertion of the pulmonary valve. J Am Coll Cardiol 2002; 39: 1664-9.
27. Bonhoeffer P, Boudjemline Y, Saliba Z, Merckx J, Aggoun Y, Bonnet D, et al. Percutaneous replacement of pulmonary valve in a right-ventricle to pulmonary-artery prosthetic conduit with valve dysfunction. Lancet 2000; 356:1403-5.
28. Cox, J.L. Heart valve replacement using flexible tubes. US5480424 (1996).
29. Cribier A, Eltchaninoff H, Bash A, Borenstein N, Tron C, Bauer F, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description. Circulation 2002; 106:3006-8.
30. Letac, B., Cribier, A. Alve prosthesis for implantation in body channels. US20010010017 (2001).
31. Letac B, Cribier, A. Valve prosthesis for implantation in body channels. US20010007956 (2001).
32. Makkar RR, Fontana GP, Jilaihawi H, Kapadia S, Pichard AD, Douglas PS, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012; 366:1696-704.
33. Letac, B., Cribier, A. Method of treating aortic stenosis using an implantable prosthetic valve. US20110087322 (2011).
34. Letac, B., Cribier, A. Implantable prosthetic valve for treating aortic stenosis. US20110040375 (2011).
35. Cribier, A. Implanting a stent valve prosthesis at the native aortic valve. US7846203 (2010).
36. Andersen, H.R., Hasenkam, J.M., Knudsen, L.L. System for implanting a valve prosthesis. US7789909 (2010).
37. Andersen, H.R., Hasenkam, J.M., Knudsen, L.L. Valve prosthesis for implantation in the body and a catheter for implanting such valve prosthesis. US 7618446 (2009).
38. Cribier, A. Methods of implanting a prosthetic heart valve within a native heart valve. US7585321 (2009).
39. Cribier, A. Value prosthesis for implantation in body channels. US6908481 (2005).
40. Andersen, H.R., Hasenkam, J.M., Knudsen, L.L. Valve prosthesis for implantation in the body and a catheter for implanting such valve prosthesis. US6582462 (2003).
41. Cribier, A. Valve prosthesis for implantation in body channels. US20050251251 (2005).
42. Cribier, A. Valve prosthesis for implantation in body channels. US20080009940 (2008).
43. Letac, B., Cribier, A. Valve prosthesis for implantation in body channels. US20080077236 (2008).
44. Seguin, J., Börtlein, G. Prosthetic valve for transluminal delivery. US20120083878 (2012).
45. Seguin, J., Börtlein, G. Prosthetic valve for transluminal delivery. US20120143316 (2012).
46. Seguin, J. Assembly for placing a prosthetic valve in a duct in the body. US20100036485 (2010).
47. Seguin, J., Nguyen, T., Lecointe, B. Implant for treatment of a heart valve, in particular a mitral valve, material including such an implant, and material for insertion thereof. US20100292785 (2010).
48. Seguin, J., Börtlein, G. Prosthetic valve for transluminal delivery. US20110125257 (2011).
49. Nguyen, T., Nguyen, H., Nguyen, M., Komatsu, S., Michiels, R. Heart valve prosthesis and methods of manufacture and use. US 20110172765 (2011).
50. Seguin, J. Assembly for placing a prosthetic valve in a duct in the body. US20110301692 (2011).
51. Toutouzas K, Michelongona A, Synetos A, Latsios G, Tsioufis C, Stefanadis C. Atrioventricular block 9days after transcatheter aortic valve implantation. Int J Cardiol 2011; 151:112-4.
52. Kempfert J, Treede H, Rastan AJ, Schönburg M, Thielmann M, Sorg S, et al. Transapical aortic valve implantation using a new self-expandable bioprosthesis (ACURATE TA): 6-month outcomes. Eur J Cardiothorac Surg, 2012. 2012 Apr 4. [Epub ahead of print].
53. Kallikazaros I, Tsioufis C, Stefanadis C, Pitsavos C, Toutouzas P. Closed relation between carotid and ascending aortic atherosclerosis in cardiac patients. Circulation 2000; 102 (19 Suppl 3): III263-8.
54. Toutouzas K, Grassos H, Synetos A, Drakopoulou M, Tsiamis E, Moldovan C, et al. A new non-invasive method for detection of local inflammation in atherosclerotic plaques: Experimental application of microwave radiometry. Atherosclerosis 2011; 215: 82-9.
55. Toutouzas K, Grassos C, Drakopoulou M, Synetos A, Tsiamis E, Aggeli C, et al. First in vivo application of microwave radiometry in human carotids: a new noninvasive method for detection of local inflammatory activation. J Am Coll Cardiol 2012; 59: 1645-53.
56. Toutouzas K, Stefanadis C, Tsiamis E, Vlachopoulos C, Tousoulis D, Tsioufis C, et al. Aortic pressure-diameter relation in patients with non-insulin dependent diabetes mellitus: New insights. Diabetologia 2000; 43:1070-5.
57. Stefanadis C, Stratos C, Vlachopoulos C, Marakas S, Boudoulas H, Kallikazaros I, et al. Pressure-diameter relation of the human aorta. A new method of determination by the application of a special ultrasonic dimension catheter. Circulation 1995; 92: 2210-9.
58. Stefanadis C, Dernellis J, Vlachopoulos C, Tsioufis C, Tsiamis E, Toutouzas K, et al. Aortic function in arterial hypertension determined by pressure-diameter relation: Effects of diltiazem. Circulation 1997; 96:1853-8.
59. Stefanadis C, Tsiamis E, Vlachopoulos C, Stratos C, Toutouzas K, Pitsavos C, et al. Aortic stiffness as a risk factor for recurrent acute coronary events in patients with ischaemic heart disease. Eur Heart J 2000; 21: 390-6.
60. Stefanadis C, Tsiamis E, Vlachopoulos C, Stratos C, Toutouzas K, Pitsavos C, et al. Unfavorable effect of smoking on the elastic properties of the human aorta. Circulation 1997; 95: 31-8.
61. Lombardi, F., Essinger, J., Delaoye, S., Hefti, J., Mantanus, L., Biadillah, Y. Stent valve, delivery apparatus and method therefor. WO2012038550 (2012).
62. Figulla, H.R., Ferrari, M., Damm, C. Device for the implantation and fixation of prosthetic valves. US8092521 (2012).